VivaVision Biotech
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.vivavisionbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About VivaVision Biotech
维眸生物是一家专注于眼科治疗领域的临床阶段创新药公司，拥有国际一流的眼科药物研发专家团队。公司已建立独特的眼科创新药研发平台，并自主研发多个创新药产品，这些产品已经或即将进入临床阶段。Explore more
Popular SearchesVivaVision Biotech IncVivaVisionVivavision Biotech LtdSIC Code 28,283NAICS Code 32,325Show moreVivaVision Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is VivaVision Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at VivaVision Biotech
Funding: Get notified immidiatlly once VivaVision Biotech has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on VivaVision Biotech recently announced quarterly report
Check if VivaVision Biotech has recently received funding, and reach out quickly before it becomes old news!
Click to see if VivaVision Biotech had a recent Job posting/layoffs
VivaVision Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when VivaVision Biotech launches new products
Check out if VivaVision Biotech is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined VivaVision Biotech as Masked Content
Find 3 more new buyers
Compare Similar Companies to VivaVision Biotech
Compare insights from companies similar to VivaVision Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
VivaVision Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
VivaVision Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about VivaVision Biotech.
VivaVision Biotech Tech Stack
A closer look at the technologies used by VivaVision Biotech
VivaVision Biotech News & Media
VivaVision Strengthens Scientific Advisory Board with a World-Renowned Expert in Ophthalmology
WENZHOU, China, Aug. 12, 2025 /PRNewswire/ -- Recently, VivaVision Biotech (Zhejiang) Co., Ltd. (VivaVision) announced the appointment of Quan Dong Nguyen, MD, MSc, FAAO, FARVO, FASRS to its Scientific Advisory Board. Quan Dong Nguyen, MD, MSc, FAAO, FARVO, FASRS, is currently a professor...VivaVision Announces Positive Comments from FDA for the Type C Meeting Regarding VVN461LD for Post-operative Infalmmation - Agreeing the Phase 2 Trial to Be Served as One of the Two Pivotal Studies.
HONG KONG and WENZHOU, China, June 9, 2025 /PRNewswire/ -- VivaVision Biotech (VivaVision), a late clinical-stage, privately-held biotech company focused on developing innovative ophthalmic drugs, announced today that it received written preliminary comments for the Type C meeting to be...VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Non-Infectious Anterior Uveitis
VVN461, a dual JAK1/TYK2 inhibitor as a non-steroidal anti-inflammatory agent, has met primary endpoints, demonstrating non-inferior efficacy compared to the standard therapy, prednisolone acetate (PA) in treating NIAU Clinically meaningful reductions in inflammation compared to baseline...VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Post-Operative Inflammation Following Cataract Surgery
VVN461, a non-steroidal dual JAK1/TYK2 immunomodulator, achieves primary endpoint, demonstrating statistical and clinical efficacy compared to vehicle in treating post-operative inflammation following cataract surgery Statistically and clinically meaningful reductions in inflammation and...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VivaVision Biotech
Sign Up For FreeTo access detailed company insights
维眸生物是一家专注于眼科治疗领域的临床阶段创新药公司，拥有国际一流的眼科药物研发专家团队。公司已建立独特的眼科创新药研发平台，并自主研发多个创新药产品，这些产品已经或即将进入临床阶段。... Read More
